Search

Displaying results 2111 - 2120 of 10000 in total
  1. Drug

    Minesapride

    go.drugbank.com/drugs/DB20801
    Experimental

    Minesapride is a small molecule drug. The usage of the INN stem '-pride' in the name indicates that Minesapride is a sulpiride derivative and analogue. … Minesapride has a monoisotopic molecular weight of 454.2 Da.

    Categories: Heterocyclic Compounds, 1-Ring, Serotonin 5-HT4 Receptor Agonists
  2. Drug

    Neutramycin

    go.drugbank.com/drugs/DB20809
    Experimental

    Neutramycin is a small molecule drug. The usage of the INN stem '-mycin' in the name indicates that Neutramycin is a antibiotic, produced by Streptomyces strain. … Neutramycin has a monoisotopic molecular weight of 686.35 Da.

    Synonyms: Neutramycin a, Chalcomycin, 6-demethyl-
  3. Drug

    Meclorisone

    go.drugbank.com/drugs/DB20850
    Experimental

    Meclorisone is a small molecule drug. Meclorisone has a monoisotopic molecular weight of 426.14 Da.

  4. Drug

    Dutacatib

    go.drugbank.com/drugs/DB20890
    Experimental

    Dutacatib is a small molecule drug. The usage of the INN stem '-catib' in the name indicates that Dutacatib is a cathepsin inhibitor. Dutacatib has a monoisotopic molecular weight of 421.26 Da.

  5. Drug

    Tizabrin

    go.drugbank.com/drugs/DB21003
    Experimental

    Tizabrin is a small molecule drug. Tizabrin has a monoisotopic molecular weight of 205.08 Da.

  6. Drug

    Enzaplatovir

    go.drugbank.com/drugs/DB21042
    Experimental

    Enzaplatovir is a small molecule drug. The usage of the INN stem '-atovir' in the name indicates that Enzaplatovir is a RSV fusion protein inhibitor. … Enzaplatovir has a monoisotopic molecular weight of 377.15 Da.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  7. Drug

    Urokinase

    go.drugbank.com/drugs/DB00013
    ApprovedInvestigationalWithdrawn

    [A191943] Urokinase remains connected between these 2 chains by a sulfhydryl bond.[A191943] Urokinase was granted FDA approval on 16 January 1978.[L12138]

    Products: UROKINASE KGCC INJ. 250000 IU FLAKON, 1 ADET, UROKINASE KGCC INJ. 500000 IU FLAKON, 1 ADET
  8. Drug

    Thyrotropin alfa

    go.drugbank.com/drugs/DB00024
    ApprovedInvestigationalVet approved

    containing one N-linked glycosylation site. … It is a heterodimeric glycoprotein comprised of two non-covalently linked subunits, an alpha subunit of 92 amino acid residues containing two N-linked glycosylation sites and a beta subunit of 112 residues

    Products: THYROGEN®, THYROGEN(R)
  9. Drug

    Anakinra

    go.drugbank.com/drugs/DB00026
    ApprovedInvestigational

    Anakinra is a recombinant human interleukin-1 (IL-1) receptor antagonist (IL-1Ra) composed of 153 amino acid residues. … This drug binds to the IL-1 receptor, competing with and inhibiting the activity of IL-1 alpha and beta.

    Synonyms: Interleukin-1 receptor antagonist anakinraCategories: Interleukin-1 Receptor Antagonist
  10. Drug

    Aldesleukin

    go.drugbank.com/drugs/DB00041
    ApprovedInvestigational

    Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. … This recombinant form differs from native interleukin-2 in the following ways: a) Aldesleukin is not glycosylated because it is derived from E. coli; b) the molecule has no N-terminal alanine; the codon

    Synonyms: 125-L-Serine-2-133-interleukin 2, 125-L-serine-2-133-interleukin 2 (human reduced)Categories: Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 CYP3A Inhibitors